Total Pelvic Exenteration for Gynecologic Malignancies

被引:42
|
作者
Diver, Elisabeth J. [1 ]
Rauh-Hain, J. Alejandro [1 ]
del Carmen, Marcela G. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Gynecol Oncol Vincent Obstet & Gynecol, 55 Fruit St,Yawkey 9E, Boston, MA 02114 USA
关键词
D O I
10.1155/2012/693535
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Total pelvic exenteration (PE) is a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In gynecologic oncology, it is most commonly indicated for the treatment of advanced primary or locally recurrent cancer. Careful patient selection and counseling are of paramount importance when considering someone for PE. Part of the evaluation process includes comprehensive assessment to exclude unresectable or metastatic disease. PE can be curative for carefully selected patients with gynecologic cancers. Major complications can be seen in as many as 50% of patients undergoing PE, underscoring the need to carefully discuss risks and benefits of this procedure with patients considering exenterative surgery.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] National trends in total pelvic exenteration for gynecologic malignancies
    Wright, Jason D.
    Chatterjee, Sudeshna
    Jones, Nathaniel
    Chen, Ling
    Tergas, Ana I.
    Burke, William M.
    Hou, June Y.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (03) : 395 - 396
  • [2] Total pelvic exenteration for pelvic malignancies
    Vermaas, M.
    van Leeuwen, D. H. J.
    Ferenschild, F. T. J.
    Verhoef, C.
    Nuyttens, J. J. M. E.
    Kirkels, W. J.
    Ansink, A. C.
    Eggermont, A. M. M.
    de Wilt, J. H. W.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 201 - 201
  • [3] Clinical outcomes of pelvic exenteration for gynecologic malignancies
    Moolenaar, L. R.
    van Rangelrooij, L. E.
    van Poelgeest, M. I. E.
    van Beurden, M.
    van Driel, W. J.
    van Lonkhuijzen, L. R. C. W.
    Mom, C. H.
    Zaal, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 171 : 114 - 120
  • [4] Performance and outcome of pelvic exenteration for gynecologic malignancies
    Matsuo, K.
    Mandelbaum, R. S.
    Adams, C. L.
    Roman, L. D.
    Wright, J. D.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 190 - 190
  • [5] PELVIC EXENTERATION IN PATIENTS WITH RECURRENT OR ADVANCED GYNECOLOGIC MALIGNANCIES
    Takuto, N.
    Shimizu, Y.
    Yoshihara, M.
    Nakamura, K.
    Yoshikawa, N.
    Suzuki, S.
    Kajiyama, H.
    Kikkawa, F.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 896 - 896
  • [6] Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies
    Mourton, SM
    Chi, DS
    Sonoda, Y
    Alektiar, KM
    Venkatraman, ES
    Barakat, RR
    Abu-Rustum, NR
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (03) : 533 - 536
  • [7] Urinary diversion after pelvic exenteration for gynecologic malignancies
    Martinez-Gomez, Carlos
    Angeles, Martina Aida
    Martinez, Alejandra
    Malavaud, Bernard
    Ferron, Gwenael
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 1 - 10
  • [8] Total Pelvic Exenteration for Primary and Recurrent Malignancies
    Ferenschild, F. T. J.
    Vermaas, M.
    Verhoef, C.
    Ansink, A. C.
    Kirkels, W. J.
    Eggermont, A. M. M.
    de Wilt, J. H. W.
    [J]. WORLD JOURNAL OF SURGERY, 2009, 33 (07) : 1502 - 1508
  • [9] Total Pelvic Exenteration for Primary and Recurrent Malignancies
    F. T. J. Ferenschild
    M. Vermaas
    C. Verhoef
    A. C. Ansink
    W. J. Kirkels
    A. M. M. Eggermont
    J. H. W. de Wilt
    [J]. World Journal of Surgery, 2009, 33 : 1502 - 1508
  • [10] National trends in total pelvic exenteration for gynecologic malignancies (vol 215, pg 395, 2016)
    Chatterjee, S.
    Chen, L.
    Jones, N.
    Tergas, A., I
    Burke, W. M.
    Hou, J. Y.
    Wright, J. D.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (05) : 530 - 530